Auszug
Adenoviren verursachen im Kindesalter Krankheiten der Atemwege und des Darms, aber auch Krankheiten der Harnwege, der Lymphorgane und kardiologische und neurologische Manifestationen werden beobachtet. Einige typische Krankheitsbilder können klinisch diagnostiziert werden.
Chapter PDF
Similar content being viewed by others
Literatur
Literatur
Brandt CD, Kim HW, Vargosko AJ et al. (1969) Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to sérologic type and illness syndrome. Am J Epidemiol 90: 484–500
Hoffman JA, Shah AJ, Ross LA, Kapoor N (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7: 388–394
McCarthy AJ, Bergin M, Silva LM de, Stevens M (1995) Intravenous ribavirin therapy for disseminated adenovirus infection. Pediatr Infect Dis J 14: 1003–1004
Schleuning M, Buxbaum-Conradi H, Jager G, Kolb HJ (2004) Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J 5: 135–144
Watzinger F, Suda M, Preuner S et al. (2004) Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 42: 5189–5198
Literatur
Gern JE, Galagan DM, Jarjour NN et al. (1997) Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155: 1159–1161
Jartti T, Lehtinen P, Vuorinen T et al. (2004) Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 10: 1095–1101
Kling S, Donninger H, Williams Z et al. (2005) Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 35: 672–678
Korppi M, Kotaniemi-Syrjanen A, Waris M et al. (2004) Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 23: 995–999
Turner RB (1997) Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 78: 531–539; quiz 539–540
Literatur
Abzug MJ, Cloud G, Bradley J et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group (2003) Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22: 335–341
Jartti T, Lehtinen P, Vuorinen T et al. (2004) Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 10: 1095–1101
Kearns GL, Bradley JS, Jacobs RF et al. (2000) Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network. Pediatr Infect Dis J 19: 833–839
Sawyer MH (2002) Enterovirus infections: diagnosis and treatment. Semin Pediatr Infect Dis 13: 40–47
Literatur
Bueving HJ, Bernsen RM, Jongste JC de et al. (2004) Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 169: 488–493
Cooper NJ, Sutton AJ, Abrams KR et al. (2003) Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 326: 1235
Denison MR (2004) Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update. Pediatr Infect Dis J 23: S207–214
Jefferson T, Smith S, Demicheli V et al. (2005) Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 365: 773–780
Johnston SL, Ferrero F, Garcia ML, Dutkowski R (2005) Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. Pediatr Infect Dis J 24: 225–232
Uyeki TM (2003) Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 22: 164–177
Literatur
Knott AM, Long CE, Hall CB (1994) Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J 13: 269–273
Lindquist SW, Darnule A, Istas A, Demmler GJ (1997) Parainfluenza virus type 4 infections in pediatric patients. Pediatr Infect Dis J 16: 34–38
Marx A, Török TJ, Holman RC et al. (1997) Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis 176: 1423–1427
Reed G, Jewett PH, Thompson J et al. (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 175: 807–813
Williams JV, Harris PA, Tollefson SJ et al. (2004) Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350: 443–450
Literatur
Anderson LJ, Heilman CA (1995) Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis 171: 1–7
Feltes TF, Cabalka AK, Meissner HC et al.; Cardiac Synagis Study Group (2003) Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 143: 532–540
IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102: 531–537
Hall CB (1998) Respiratory syncytial virus. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. Saunders, Philadelphia, pp 2084–2111
Wang EE, Law BJ, Stephens D (1995) Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 126: 212–219
Literatur
Crowe JE Jr (2004) Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J 23[Suppl 11]: S215–221
Hoogen BG van den, Jong JC de, Groen J et al. (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7: 719–724
König B, König W, Arnold R et al. (2004) Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 42: 4632–4635
Williams JV, Harris PA, Tollefson SJ et al. (2004) Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350: 443–450
Literatur
Arenz S, Schmitt HJ, Tischer A, Kries R von (2005) Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria. Pediatr Infect Dis J 24: 697–699
Avota E, Avots A, Niewiesk S et al. (2001) Disruption of Akt Kinase activation is important for immunosuppression induced by measles virus. Nat Med 7: 725–731
Brodsky AL (1972) Atypical measles: severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. JAMA 222: 1415–1416
Coutsoudis A, Broughton M, Coovadia HH (1991) Vitamin A supplementation reduces measles morbidity in young African children: a randomized placebo-controlled, double-blind trial. Am J Clin Nutr 54: 890–895
Forni AL, Schluger NW, Robert RB (1994) Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis 19: 454–462
Gendelman KE, Wolinsky JS, Johnson RT et al. (1984) Measles encephalitis: lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination. Ann Neurol 15: 353–360
Markowitz LE, Chandler FW, Roldan EO et al. (1988) Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis 158: 480–483
Mustafa MM, Weitman SD, Winick NJ et al. (1993) Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 16: 654–660
Perry RT, Halsey NA (2004) The clinical significance of measles: a review. J Infect Dis 189[Suppl 1]: S4–16
Literatur
Belay ED, Holman RC, Schonberger LB (2005) Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis 41: 834–836
Bellini WJ, Rota JS, Lowe LE et al. (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192: 1686–1693
Brown P (1988) Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics 81: 85–92
Domes K (1997) New aspects in the pathogenesis of polyomavirus-induced disease. Adv Virus Res 48: 205–261
Flechsig E, Weissmann C (2004) The role of PrP in health and disease. Curr Mol Med 4: 337–353
Hosoya M, Mori S, Tomoda A et al. (2004) Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob Agents Chemother 48: 4631–4635
Kretzschmar H (1999) Transmissible spongiforme Enzephalopathien (Prionkrankheiten). In: Hopf HC, Deuschl G, Diener HC (Hrsg) Neurologie in Praxis und Klinik, 2. Aufl. Thieme, Stuttgart
Langer-Gould A, Atlas SW, Green AJ et al. (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353: 375–381
Martin R, Marquardt P, O’Shea S et al. (1989) Virus specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J Neuroimmunol 23: 1–10
Miller C, Farrington CP, Harbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970–1989. Int J Epidemiol 21: 998–1006
Nasemann JE, Schmid C, Schneider A et al. (1996) Äußere Retinitis als Frühsymptom bei subakut sklerosierender Panenzephalitis (SSPE). Klin Monatsbl Augenheilkd 206: 122–127
Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515–1522
Redfearn A, Pennie RA, Mahony JB, Dent PB (1993) Progressive multifocal leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M. Pediatr Infect Dis J 12: 399–401
Steelman VM (1994) Creutzfeldt-Jakob disease: recommendations for infection control. Am J Infect Control 22: 312–318
Vandersteenhoven JJ, Dbaibo G, Boyko OB et al. (1992) Progressive multifocal leukoencephalopathy in pediatric acquired immunodeficiency syndrome. Pediatr Infect Dis J 11: 232–237
Will RG, Ironside JW, Zeidler M et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925
Zwiauer K, Forstenpointner E, Popow-Kraupp T et al. (1995) Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infections. Lancet 345: 1124
Literatur
Bayer WL, Sherman FE, Michaels RH et al. (1965) Purpura in congenital and acquired rubella. N Engl J Med 273: 1362–1366
Bitzan M (1987) Rubella myelitis and encephalitis in childhood. A report of two cases with magnetic resonance imaging. Neuropediatrics 18: 84–87
Dwyer DE, Hueston L, Field PR et al. (1992) Acute encephalitis complicating rubella virus infection. Pediatr Infect Dis J 11: 238–240
Enders G, Knotek F (1989) Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 17: 218–226
Frenkel LM, Nielsen K, Garakian A et al. (1996) A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin Infect Dis 22: 287–294
Literatur
Casella R, Leibundgut B, Lehmann K, Gasser TC (1997) Mumps orchitis: report of a mini-epidemic. J Urol 158: 2158–2161
Hall R, Richards H (1987) Hearing loss due to mumps. Arch Dis Child 62: 189–192
Helmke K, Often A, Willems WR et al. (1986) Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination. Diabetologia 29: 30–33
Hviid A, Stellfeld M, Wohlfahrt J, Melbye M (2004) Childhood vaccination and type 1 diabetes. N Engl J Med 350: 1398–1404
Vaheri A, Julkunen I, Koskiniemi ML (1982) Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies. Lancet 2: 685–688
Vandvik B, Norrby E, Steen-Johnson J, Stensvold K (1978) Mumps meningitis: prolonged pleocytosis and occurrence of mumps-specific oligoclonal IgG in the cerebrospinal fluid. Eur Neurol 17: 13–22
Literatur
Asano Y, Yoshikawa T, Suga S et al. (1994) Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93: 104–108
Caserta MT, McDermott MP, Dewhurst S et al. (2004) Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J Pediatr 145: 478–484
Hall CB, Caserta MT, Schnabel KC et al (2004). Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 145: 472–477
Suga S, Suzuki K, Ihira M et al. (2000) Clinical characteristics of febrile convulsions during primary HHV-6 infection. Arch Dis Child 82: 62–66
Tokimasa S, Hara J, Osugi Y et al. (2002) Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 29: 595–598
Ward KN, Andrews NJ, Verity CM et al. (2005) Human herpesviruses-6 and-7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 90: 619–623
Yoshihara S, Kato R, Inoue T et al (2004) Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. Transplantation 77: 835–838
Zerr DM, Meier AS, Selke SS et al. (2005) A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352: 768–776
Literatur
Boutolleau D, Fernandez C, Andre E et al. (2003) Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187: 179–186
Broccolo F, Drago F, Careddu AM et al. (2005) Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and-7. J Invest Dermatol 124: 1234–1240
Caserta MT, Hall CB, Schnabel K et al. (1998) Primary human herpesvirus 7 infection: a comparisation of human herpesvirus 7 and human herpesvirus 6 infections in children. J Pediatr 133: 386–389
Chan PK, Li CK, Chik KW et al. (2004) Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients. J Med Virol 72: 668–674
Levy JA (1997) Three new human herpesviruses (HHV6, 7, and 8). Lancet 349: 558–563
Takahashi Y, Yamada M, Nakamura J et al. (1997) Transmission of human herpesvirus 7 through multigenerational families in the same household. Pediatr Infect Dis J 16: 975–978
Torigoe S, Kumamoto T, Koide W et al. (1995) Clinical manifestations associated with human herpesvirus 7 infection. Arch Dis Child 72: 518–519
Literatur
Bhaduri-Mclntosh S (2005) Human herpesvirus-8: clinical features of an emerging viral pathogen. Pediatr Infect Dis J 24: 81–82
Camcioglu Y, Picard C, Lacoste V et al. (2004) HHV-8-associated Kaposi sarcoma in a child with IFNgammaRl deficiency. J Pediatr 144: 519–523
Chen RL, Lin JC, Wang PJ et al. (2004) Human herpesvirus 8-related childhood mononucleosis: a series of three cases. Pediatr Infect Dis J 23: 671–674
Plancoulaine S, Abel L, Beveren M van et al. (2000) Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356: 1062–1065
Wheat WH, Cool CD, Morimoto Y et al. (2005) Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 202: 479–484
Literatur
Anderson MJ, Higgins PG, David LR et al. (1985) Experimental parvoviral infection in humans. J Infect Dis 152: 257–265
Brown KE, Hibbs JR, Gallinella G et al. (1994) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 330: 1192–1196
Heegaard ED, Hornsleth A (1995) Parvovirus: the expanding spectrum of disease. ActaPaediatr 84: 109–117
Lehmann HW, Landenberg P von, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2: 218–223
Levy R, Weissman A, Blomberg G, Hagy ZJ (1997) Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Surv 52: 254–259
Servant A, Laperche S, Lallemand F et al. (2002) Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 76: 9124–9134
Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350: 586–597
Literatur
Kimura H, Aso K, Kuzushima K et al. (1992) Relapse of herpes simplex encephalitis in children. Pediatrics 89: 891–894
Schuster V, Handrick W, Korn K et al. (2007) Herpes-simplex-Virus-Infektionen. In: Scholz H, Belohradsky BH, Heininger U et al. (Hrsg) Handbuch Infektionen bei Kindern und Jugendlichen, 5. Aufl. DGPI/Futuramed, München (im Druck)
Wagstaff AJ, Faulds D, Goa KL (1994) Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 153–205
Kimberlin D (2004) Herpes simplex virus, meningitis and encephalitis in neonates (review). Herpes 11[Suppl2]: 65A–76A
Literatur
Enders G, Miller E, Cradock-Watson J et al. (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343: 1548–1551
Gilden D (2004) Varicella zoster virus and central nervous system syndromes. Herpes 11[Suppl 2]: 89A–94A
Leung TF, Chik KW, Li CK et al. (2000) Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 25: 167–172
Lin TY, Huang YC, Ning HC, Hsueh C (1997) Oral acyclovir prophylaxis of varicella after intimate contact. Pediatr Infect Dis J 16: 1162–1165
Ozaki T, Kajita Y, Asano Y et al. (1994) Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol 44: 263–265
Wutzler P, Färber I, Wagenpfeil S et al. (2001) Seroprevalence of varicellazoster virus in the German population. Vaccine 20: 121–124
Literatur
Boppana SB, Pass RF, Britt WJ et al. (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11: 93–99
Fowler KB, Stagno S, Pass RF et al. (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326: 663–667
Frenkel LM, Capparelli EV, Dankner WM et al. (2000) Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect Dis 182: 1616–1624
Hamprecht K, Maschmann J, Muller D et al. (2004) Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 56: 529–535
Kimberlin DW, Lin CY, Sanchez PJ et al. (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143: 16–25
Meijer E, Boland GJ, Verdonck LF (2003) Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev 16: 647–657
Vollmer B, Seibold-Weiger K, Schmitz-Salue C et al (2004) Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr Infect Dis J 23: 322–327
Literatur
Callan MF, Tan L, Anneis N et.al. (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187: 1395–1402
Clave E, Agbalika F, Bajzik V et al. (2004) Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation 77: 76–84
Gruhn B, Meerbach A, Hafer R et al. (2003) Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 31: 1023–1025
Imashuku S, Hibi S, Ohara T et al. (1999) Effective control of Epstein-Barr virus related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 93: 1869–1874
Jenson HB (2000) Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr 12: 263–268
McClain KL, Leach CT, Jenson HB et al. (1995) Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 332: 12–18
Milone MC, Tsai DE, Hodinka RL et al. (2005) Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 105: 994–996
Schuster V, Hügle B, Tefs K, Borte M (2002) Atypische Epstein-Barr-Virus (EBV)-Infektionen im Kindes-und Jugendalter. Monatsschr Kinderheilkd 150: 1154–1167
Literatur
Bielefeldt-Ohmann H (1997) Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol 5: 409–413
Bitzan M (1997) Hämorrhagische Fieber und Hantavirus-Infektionen. In: Deutsche Gesellschaft für Pädiatrische Infektiologie (Hrsg) Handbuch. Infektionen bei Kindern und Jugendlichen, 2. Aufl. Futuramed, München, S 295–307
Bray M (2005) Pathogenesis of viral hemorrhagic fever. Curr Opinion Immunol 17: 399–403
Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10[Suppl 12]: S110–121
Kautner I, Robinson MJ, Kuhnle U (1997) Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis and prevention. J Pediatr 131: 516–524
Mackenzie JS, Gubler DJ, Petersen LR (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10[Suppl 12]: S98–109
Monath TP, Cetron MS (2002) Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369–1378
Pigott DC (2005) Hemorrhagic fever viruses. Crit Care Clin 21: 765–783
Robertson SE, Hull BP, Tomori O et al. (1996) Yellow fever: a decade of reemergence. JAMA 276: 1157–1162
Tsai TF (1997a) Ebola and Marburg viruses. In: Long SS, Pickering LK, Prober CG (eds) Pediatric infectious diseases. Churchill Livingstone, New York, pp 1274–1275
Tsai TF (1997b) Lymphocytic choriomeningitis virus, Lassa fever virus, and other arenaviruses. In: Long SS, Pickering LK, Prober CG (eds) Pediatric infectious diseases. Churchill Livingstone, New York, pp 1275–1278
Willis BA, Nguyen MD, Ha TL et al. (2005) Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 353: 877–889
Literatur
Bear GM (ed) (1991) The natural history of rabies, 2nd edn. CRC, Boca Raton/FL
Roß RS, Kruppenbacher JP, Schiller WG et al. (1997) Menschliche Tollwuterkrankung in Deutschland. Dtsch Arztebl 94: 29–32
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Forster, J., Schuster, V., Kreth, H.W., Nadal, D., Schmitt, H.J. (2007). Virale Infektionen. In: Lentze, M.J., Schulte, F.J., Schaub, J., Spranger, J. (eds) Pädiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76460-1_100
Download citation
DOI: https://doi.org/10.1007/978-3-540-76460-1_100
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71895-6
Online ISBN: 978-3-540-76460-1
eBook Packages: Medicine (German Language)